These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19892545)

  • 21. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
    Hakomori S
    Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function.
    Mitra N; Sinha S; Ramya TN; Surolia A
    Trends Biochem Sci; 2006 Mar; 31(3):156-63. PubMed ID: 16473013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum synthesizes O-glycosylated glycoproteins containing O-linked N-acetylglucosamine.
    Nasir-ud-Din ; Drager-Dayal R; Decrind C; Hu BH; Del Giudice G; Hoessli D
    Biochem Int; 1992 Jun; 27(1):55-64. PubMed ID: 1627179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
    Gerngross TU
    Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioprospecting in plants for engineered proteins.
    Joshi L; Lopez LC
    Curr Opin Plant Biol; 2005 Apr; 8(2):223-6. PubMed ID: 15753005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of glycosylation in the transport of recombinant glycoproteins through the secretory pathway of lepidopteran insect cells.
    Jarvis DL; Oker-Blom C; Summers MD
    J Cell Biochem; 1990 Apr; 42(4):181-91. PubMed ID: 2341487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli.
    Wacker M; Linton D; Hitchen PG; Nita-Lazar M; Haslam SM; North SJ; Panico M; Morris HR; Dell A; Wren BW; Aebi M
    Science; 2002 Nov; 298(5599):1790-3. PubMed ID: 12459590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of mushroom-forming fungi for the production of N-glycosylated therapeutic proteins.
    Berends E; Scholtmeijer K; Wösten HA; Bosch D; Lugones LG
    Trends Microbiol; 2009 Oct; 17(10):439-43. PubMed ID: 19758804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sugar added. Cheaper, better protein drugs through sweetening.
    Gibbs W
    Sci Am; 2003 Jul; 289(1):23-4. PubMed ID: 12840940
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development.
    Patten PA; Schellekens H
    Dev Biol (Basel); 2003; 112():81-97. PubMed ID: 12762507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein glycosylation in development and disease.
    Dennis JW; Granovsky M; Warren CE
    Bioessays; 1999 May; 21(5):412-21. PubMed ID: 10376012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins.
    Brooks SA
    Expert Rev Proteomics; 2006 Jun; 3(3):345-59. PubMed ID: 16771706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
    Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
    Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The humanization of N-glycosylation pathways in yeast.
    Wildt S; Gerngross TU
    Nat Rev Microbiol; 2005 Feb; 3(2):119-28. PubMed ID: 15685223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-translational modifications in the context of therapeutic proteins.
    Walsh G; Jefferis R
    Nat Biotechnol; 2006 Oct; 24(10):1241-52. PubMed ID: 17033665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA: an immune glycoprotein.
    Yoo EM; Morrison SL
    Clin Immunol; 2005 Jul; 116(1):3-10. PubMed ID: 15925826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A serial lectin approach to the mucin-type O-glycoproteome of Drosophila melanogaster S2 cells.
    Schwientek T; Mandel U; Roth U; Müller S; Hanisch FG
    Proteomics; 2007 Sep; 7(18):3264-77. PubMed ID: 17708590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved secretion of human Fas ligand extracellular domain by N-terminal part truncation in Pichia pastoris and preparation of the N-linked carbohydrate chain trimmed derivative.
    Muraki M
    Protein Expr Purif; 2008 Aug; 60(2):205-13. PubMed ID: 18501631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.